Management of Primary and Recurrent Clostridium difficile Infection: An Update
Open Access
- 30 June 2018
- journal article
- review article
- Published by MDPI AG in Antibiotics
- Vol. 7 (3) , 54
Abstract
Background: Clostridium difficile infection (CDI) is one of the most common healthcare-associated infections (HAI) in the United States and Canada, and incidence rates have increased worldwide in recent decades. Currently, antibiotics are the mainstay treatments for both primary and recurrent CDI, but their efficacy is limited, prompting further therapies to be developed. Aim: This review summarizes current and emerging therapies in CDI management including antibiotics, fecal microbiota transplantation, monoclonal antibodies, spore-based therapies, and vaccinations.Keywords
This publication has 48 references indexed in Scilit:
- Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapiesJournal of Hospital Infection, 2018
- Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United StatesAnnals of Internal Medicine, 2017
- Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility TestingJournal of Clinical Microbiology, 2017
- A Review of Management of Clostridium difficile Infection: Primary and RecurrenceAntibiotics, 2015
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled TrialsClinical Infectious Diseases, 2014
- Multistate Point-Prevalence Survey of Health Care–Associated InfectionsNew England Journal of Medicine, 2014
- Burden of Clostridium difficile on the Healthcare SystemClinical Infectious Diseases, 2012
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile DiseaseAmerican Journal of Gastroenterology, 2002
- Structure, biochemistry and mechanism of action of glycopeptide antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989